Sns Financial Group Cut Abbvie (ABBV) Position By $4.99 Million; Andra Ap-Fonden Has Trimmed Its Varian Med Sys (VAR) Stake

May 24, 2018 - By Jacob Smith

AbbVie Inc. (NYSE:ABBV) Logo

Sns Financial Group Llc decreased Abbvie Inc (ABBV) stake by 79.98% reported in 2017Q4 SEC filing. Sns Financial Group Llc sold 52,018 shares as Abbvie Inc (ABBV)’s stock declined 6.31%. The Sns Financial Group Llc holds 13,024 shares with $1.26 million value, down from 65,042 last quarter. Abbvie Inc now has $163.27 billion valuation. The stock decreased 2.57% or $2.715 during the last trading session, reaching $102.885. About 8.39M shares traded or 14.98% up from the average. AbbVie Inc. (NYSE:ABBV) has risen 39.20% since May 24, 2017 and is uptrending. It has outperformed by 27.65% the S&P500.

Andra Ap-Fonden decreased Varian Med Sys Inc (VAR) stake by 18.27% reported in 2017Q4 SEC filing. Andra Ap-Fonden sold 22,600 shares as Varian Med Sys Inc (VAR)’s stock rose 9.85%. The Andra Ap-Fonden holds 101,100 shares with $11.24M value, down from 123,700 last quarter. Varian Med Sys Inc now has $10.88B valuation. The stock decreased 0.02% or $0.02 during the last trading session, reaching $118.93. About 450,605 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 32.94% since May 24, 2017 and is uptrending. It has outperformed by 21.39% the S&P500.

Among 23 analysts covering Abbvie Inc (NYSE:ABBV), 10 have Buy rating, 2 Sell and 11 Hold. Therefore 43% are positive. Abbvie Inc had 92 analyst reports since July 21, 2015 according to SRatingsIntel. Argus Research maintained AbbVie Inc. (NYSE:ABBV) rating on Friday, February 2. Argus Research has “Buy” rating and $145 target. Leerink Swann maintained the stock with “Buy” rating in Tuesday, December 5 report. Morgan Stanley upgraded the shares of ABBV in report on Monday, November 2 to “Overweight” rating. Morgan Stanley maintained the shares of ABBV in report on Tuesday, January 30 with “Equal-Weight” rating. The rating was maintained by BMO Capital Markets with “Hold” on Friday, April 28. The firm earned “Buy” rating on Monday, February 26 by Jefferies. SunTrust initiated AbbVie Inc. (NYSE:ABBV) on Wednesday, July 22 with “Buy” rating. The company was maintained on Monday, May 29 by Jefferies. The rating was maintained by Jefferies with “Buy” on Thursday, May 25. As per Sunday, October 29, the company rating was maintained by SunTrust.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.05, from 0.85 in 2017Q3. It fall, as 42 investors sold ABBV shares while 695 reduced holdings. 139 funds opened positions while 448 raised stakes. 1.06 billion shares or 0.35% more from 1.06 billion shares in 2017Q3 were reported. Minnesota-based Mairs And Pwr Incorporated has invested 0.2% in AbbVie Inc. (NYSE:ABBV). Crawford Counsel holds 0.07% or 23,657 shares. 36,888 were reported by Kidder Stephen W. Salem Inc owns 8,000 shares. 22,727 are held by Argi Invest Ltd Company. Iguana Management stated it has 50,000 shares or 3.15% of all its holdings. The Ontario – Canada-based National Bank & Trust Of Montreal Can has invested 0.45% in AbbVie Inc. (NYSE:ABBV). Amalgamated Bancorporation owns 0.55% invested in AbbVie Inc. (NYSE:ABBV) for 210,646 shares. Spark Mngmt Ltd Co reported 0.58% stake. Woodmont Counsel Limited Liability Company has 28,369 shares for 0.71% of their portfolio. Meristem Limited Liability Partnership has invested 0.37% in AbbVie Inc. (NYSE:ABBV). Us Bancshares De reported 2.92M shares stake. Koshinski Asset Mgmt holds 0.78% of its portfolio in AbbVie Inc. (NYSE:ABBV) for 32,336 shares. Covington Investment Inc invested in 30,836 shares or 1.02% of the stock. Sanders Cap Ltd Liability Corporation has invested 0.3% of its portfolio in AbbVie Inc. (NYSE:ABBV).

Since December 14, 2017, it had 0 insider purchases, and 11 insider sales for $47.70 million activity. CHASE WILLIAM J also sold $8.31M worth of AbbVie Inc. (NYSE:ABBV) shares. RICHMOND TIMOTHY J. sold $2.15 million worth of stock. Michael Robert A. sold $119,351 worth of AbbVie Inc. (NYSE:ABBV) on Monday, February 19. 2,643 shares were sold by SEVERINO MICHAEL, worth $311,684 on Wednesday, February 28. $14.07 million worth of AbbVie Inc. (NYSE:ABBV) was sold by Schumacher Laura J on Thursday, December 14. 8,280 AbbVie Inc. (NYSE:ABBV) shares with value of $976,084 were sold by GONZALEZ RICHARD A. 83,574 AbbVie Inc. (NYSE:ABBV) shares with value of $9.57M were sold by ALBAN CARLOS.

Sns Financial Group Llc increased Claymore Exchange Trd Fd Tr (BSCI) stake by 31,968 shares to 264,559 valued at $5.58 million in 2017Q4. It also upped Green Plains Partners Lp stake by 83,113 shares and now owns 353,113 shares. Vanguard Bd Index Fd Inc (BND) was raised too.

More important recent AbbVie Inc. (NYSE:ABBV) news were published by: Streetinsider.com which released: “AbbVie (ABBV) Reports IMBRUVICA (ibrutinib) Plus GAZYVA (obinutuzumab) Phase 3 iLLUMINATE (PCYC-1130 …” on May 24, 2018, also Seekingalpha.com published article titled: “AbbVie: Can Mylan Pull Off A Humira Biosimilar?”, 247Wallst.com published: “Why One Old Stock Buyback Trick Is Working So Well for AbbVie” on May 01, 2018. More interesting news about AbbVie Inc. (NYSE:ABBV) was released by: Seekingalpha.com and their article: “AbbVie Is Still A One-Trick Pony” with publication date: April 26, 2018.

Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on July, 27. They expect $1.97 EPS, up 38.73% or $0.55 from last year’s $1.42 per share. ABBV’s profit will be $3.13B for 13.06 P/E if the $1.97 EPS becomes a reality. After $1.87 actual EPS reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 5.35% EPS growth.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.22, from 1.02 in 2017Q3. It dropped, as 37 investors sold VAR shares while 194 reduced holdings. 63 funds opened positions while 122 raised stakes. 87.00 million shares or 3.31% less from 89.98 million shares in 2017Q3 were reported. Bp Pcl has invested 0.04% in Varian Medical Systems, Inc. (NYSE:VAR). Plancorp Lc holds 6,528 shares. State Farm Mutual Automobile reported 0.03% in Varian Medical Systems, Inc. (NYSE:VAR). 6,341 were accumulated by Wms Prtnrs Limited Liability Corporation. Thompson Rubinstein Or reported 35,400 shares stake. Point72 Asset Management LP has invested 0.02% in Varian Medical Systems, Inc. (NYSE:VAR). Willis Investment Counsel stated it has 0.61% in Varian Medical Systems, Inc. (NYSE:VAR). Greenleaf Tru accumulated 0.01% or 3,628 shares. 1,669 are held by Northwestern Mutual Wealth Management. Farmers & Merchants Invests has invested 0% in Varian Medical Systems, Inc. (NYSE:VAR). Japan-based Meiji Yasuda Asset Mngmt Ltd has invested 0.12% in Varian Medical Systems, Inc. (NYSE:VAR). 3,733 were accumulated by Thrivent For Lutherans. Transamerica Fincl holds 0.11% or 7,568 shares. Ashfield Cap Prtn Ltd Liability Com reported 0.11% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Washington Cap Inc stated it has 0.51% in Varian Medical Systems, Inc. (NYSE:VAR).

More important recent Varian Medical Systems, Inc. (NYSE:VAR) news were published by: Seekingalpha.com which released: “Varian Medical Systems (VAR) Q2 2018 Results – Earnings Call Transcript” on April 26, 2018, also Benzinga.com published article titled: “Varian to Present at Jefferies Global Healthcare Conference”, Twst.com published: “Varian Medical Systems Inc.: Varian Notifies Sirtex It Will Not Submit a Counterproposal to Competing Bid” on May 22, 2018. More interesting news about Varian Medical Systems, Inc. (NYSE:VAR) was released by: Globenewswire.com and their article: “Recent Analysis Shows Liberty Broadband, Primerica, Adtalem Global Education, Newpark Resources, Varian Medical …” with publication date: May 15, 2018.

Andra Ap-Fonden increased Crown Holdings Inc (NYSE:CCK) stake by 12,600 shares to 69,200 valued at $3.89M in 2017Q4. It also upped Constellation Brands Inc (NYSE:STZ) stake by 1,500 shares and now owns 43,000 shares. Eqt Corp (NYSE:EQT) was raised too.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on July, 25. They expect $1.00 EPS, down 3.85% or $0.04 from last year’s $1.04 per share. VAR’s profit will be $91.51 million for 29.73 P/E if the $1.00 EPS becomes a reality. After $1.15 actual EPS reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -13.04% negative EPS growth.

Among 12 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. Varian Medical Systems Inc. had 39 analyst reports since August 27, 2015 according to SRatingsIntel. The rating was downgraded by Robert W. Baird on Tuesday, October 20 to “Neutral”. Barrington Research reinitiated Varian Medical Systems, Inc. (NYSE:VAR) rating on Tuesday, January 12. Barrington Research has “Outperform” rating and $91 target. The rating was maintained by RBC Capital Markets on Thursday, November 30 with “Hold”. Jefferies maintained Varian Medical Systems, Inc. (NYSE:VAR) on Wednesday, October 25 with “Buy” rating. On Thursday, April 26 the stock rating was maintained by Jefferies with “Buy”. The company was maintained on Thursday, January 25 by JP Morgan. Evercore downgraded the stock to “Sell” rating in Thursday, January 26 report. Jefferies maintained the shares of VAR in report on Sunday, September 10 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Friday, July 14. The stock has “Neutral” rating by Citigroup on Thursday, November 12.

Since December 12, 2017, it had 0 insider purchases, and 22 insider sales for $22.58 million activity. On Tuesday, January 16 KUO JOHN W sold $93,575 worth of Varian Medical Systems, Inc. (NYSE:VAR) or 863 shares. The insider KENNEDY KOLLEEN T sold 3,513 shares worth $425,622. WILSON DOW R had sold 24,000 shares worth $2.83M. LARET MARK R had sold 2,161 shares worth $274,383 on Thursday, February 1. Another trade for 10,000 shares valued at $1.11M was sold by GUERTIN TIMOTHY E. $196,792 worth of Varian Medical Systems, Inc. (NYSE:VAR) was sold by MOMSEN MAGNUS. On Thursday, February 22 BOSTROM SUSAN L sold $235,413 worth of Varian Medical Systems, Inc. (NYSE:VAR) or 1,952 shares.

Varian Medical Systems, Inc. (NYSE:VAR) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts

>